RU2007107494A - Трициклические производные инденопиррола как модуляторы серотининовых рецепторов, фармацевтическая композиция на их основе и способ лечения заболеваний, растройств и/или патологических состояний, связанных с необходимостью модуляции функции 5-нт2с рецепторов - Google Patents

Трициклические производные инденопиррола как модуляторы серотининовых рецепторов, фармацевтическая композиция на их основе и способ лечения заболеваний, растройств и/или патологических состояний, связанных с необходимостью модуляции функции 5-нт2с рецепторов Download PDF

Info

Publication number
RU2007107494A
RU2007107494A RU2007107494/04A RU2007107494A RU2007107494A RU 2007107494 A RU2007107494 A RU 2007107494A RU 2007107494/04 A RU2007107494/04 A RU 2007107494/04A RU 2007107494 A RU2007107494 A RU 2007107494A RU 2007107494 A RU2007107494 A RU 2007107494A
Authority
RU
Russia
Prior art keywords
alkyl
hexahydroindeno
pyrrole
heteroaryl
methyl
Prior art date
Application number
RU2007107494/04A
Other languages
English (en)
Russian (ru)
Inventor
Бейард ХАК (US)
Бейард ХАК
Юссеф Л. БЕННАНИ (US)
Юссеф Л. Беннани
Майкл Дж. РОБАРДЖ (US)
Майкл Дж. РОБАРДЖ
Original Assignee
Эсерсис, Инк. (US)
Эсерсис, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эсерсис, Инк. (US), Эсерсис, Инк. filed Critical Эсерсис, Инк. (US)
Publication of RU2007107494A publication Critical patent/RU2007107494A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2007107494/04A 2004-07-29 2005-07-26 Трициклические производные инденопиррола как модуляторы серотининовых рецепторов, фармацевтическая композиция на их основе и способ лечения заболеваний, растройств и/или патологических состояний, связанных с необходимостью модуляции функции 5-нт2с рецепторов RU2007107494A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59204704P 2004-07-29 2004-07-29
US60/592047 2004-07-29

Publications (1)

Publication Number Publication Date
RU2007107494A true RU2007107494A (ru) 2008-09-10

Family

ID=37075566

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007107494/04A RU2007107494A (ru) 2004-07-29 2005-07-26 Трициклические производные инденопиррола как модуляторы серотининовых рецепторов, фармацевтическая композиция на их основе и способ лечения заболеваний, растройств и/или патологических состояний, связанных с необходимостью модуляции функции 5-нт2с рецепторов

Country Status (16)

Country Link
US (5) US20060025601A1 (enExample)
EP (1) EP1841738A4 (enExample)
JP (1) JP4990164B2 (enExample)
KR (2) KR20130047765A (enExample)
CN (1) CN101516372A (enExample)
AR (1) AR050274A1 (enExample)
AU (1) AU2005333518B2 (enExample)
BR (1) BRPI0512869A (enExample)
CA (1) CA2603249C (enExample)
IL (1) IL180977A (enExample)
NO (1) NO20071102L (enExample)
NZ (1) NZ552806A (enExample)
RU (1) RU2007107494A (enExample)
TW (1) TWI377195B (enExample)
WO (1) WO2007081299A2 (enExample)
ZA (1) ZA200700684B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4990164B2 (ja) * 2004-07-29 2012-08-01 アサーシス， インク． セロトニン受容体モジュレーターとしての三環系インデノ−ピロール誘導体
EP2727585A1 (en) 2006-05-16 2014-05-07 Takeda Pharmaceutical Company Limited In-vivo screening method
EP1988091B1 (en) 2007-02-07 2015-06-10 Kyowa Hakko Kirin Co., Ltd. Tricyclic compounds
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
WO2009097995A1 (de) * 2008-02-07 2009-08-13 Sanofi-Aventis Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
JP5559689B2 (ja) 2008-08-06 2014-07-23 協和発酵キリン株式会社 ３環系化合物
TW201041851A (en) 2009-03-10 2010-12-01 Organon Nv Tricyclic heterocyclic derivatives
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
CN106380440B (zh) * 2016-08-30 2019-02-01 华东师范大学 一种茚酮并吡咯类衍生物及其合成方法和应用
CN106631989B (zh) * 2016-11-26 2019-07-16 威海迪素制药有限公司 一种盐酸多奈哌齐有关物质e的制备方法
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0170093B1 (en) * 1984-07-25 1990-03-07 Abbott Laboratories 1,2,3,3a,8,8a-hexahydro-indeno-(1,2-c)pyrrdes
US4622405A (en) * 1984-07-25 1986-11-11 Abbott Laboratories 1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
ATE139230T1 (de) * 1988-12-15 1996-06-15 Abbott Lab 5-ht-selektive mittel
US5244888A (en) * 1989-11-17 1993-09-14 Abbott Laboratories 5-HT selective agents
TW334423B (en) * 1993-10-22 1998-06-21 Hoffmann La Roche Tricyclic 1-aminoethylpyrrole-derivatives
US7351711B2 (en) * 2003-07-31 2008-04-01 Janssen Pharmaceutical, N.V. Tricyclic indanyls as integrin inhibitors
TWI350168B (en) * 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
JP4990164B2 (ja) * 2004-07-29 2012-08-01 アサーシス， インク． セロトニン受容体モジュレーターとしての三環系インデノ−ピロール誘導体

Also Published As

Publication number Publication date
CA2603249C (en) 2014-01-21
TWI377195B (en) 2012-11-21
US20140206739A1 (en) 2014-07-24
IL180977A (en) 2012-08-30
AU2005333518A1 (en) 2007-02-22
KR101257233B1 (ko) 2013-04-29
AU2005333518A8 (en) 2008-08-07
CA2603249A1 (en) 2007-07-19
BRPI0512869A (pt) 2008-04-08
ZA200700684B (en) 2008-10-29
US9096520B2 (en) 2015-08-04
US20060025601A1 (en) 2006-02-02
US7935830B2 (en) 2011-05-03
JP4990164B2 (ja) 2012-08-01
US20120252859A1 (en) 2012-10-04
KR20080025657A (ko) 2008-03-21
IL180977A0 (en) 2009-02-11
NZ552806A (en) 2009-09-25
AU2005333518B2 (en) 2010-12-02
NO20071102L (no) 2007-04-20
WO2007081299A3 (en) 2007-09-20
AR050274A1 (es) 2006-10-11
JP2008508365A (ja) 2008-03-21
US20110172283A1 (en) 2011-07-14
TW200619196A (en) 2006-06-16
US20090239925A1 (en) 2009-09-24
US8716324B2 (en) 2014-05-06
CN101516372A (zh) 2009-08-26
EP1841738A2 (en) 2007-10-10
US8232311B2 (en) 2012-07-31
EP1841738A4 (en) 2010-06-02
KR20130047765A (ko) 2013-05-08
WO2007081299A2 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
RU2007107494A (ru) Трициклические производные инденопиррола как модуляторы серотининовых рецепторов, фармацевтическая композиция на их основе и способ лечения заболеваний, растройств и/или патологических состояний, связанных с необходимостью модуляции функции 5-нт2с рецепторов
TWI374141B (en) Spiro-oxindole compounds and their uses as therapeutic agents
JP6495868B2 (ja) キナーゼ阻害剤の組成物ならびに癌およびキナーゼに関連する他の疾患の治療のためのそれらの使用
CA2657106A1 (en) Aminoindane derivative or salt thereof
CA3138144A1 (en) Substituted cyclolakyls as modulators of the integrated stress pathway
WO2010014613A3 (en) Treating various disorders using trkb agonists
RU2018103944A (ru) Производные этинила как модуляторы метаботропного рецептора глутамата
NO20072116L (no) Farmasoytiske forbindelser
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
EA200901159A1 (ru) Производные 3-циано-4-(4-фенилпиперидин-1-ил)пиридин-2-она
RU95104322A (ru) Производные дефинила, способы их получения, фармкомпозиция и способ лечения
RU2015120478A (ru) Пери-карбинолы
RU2009136996A (ru) Трициклические соединения, которые можно использовать для лечения нарушений, связанных с анормальным уровнем содержания железа в организме
CN111601797A (zh) 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用
RU2017134668A (ru) Девятичленное конденсированное кольцевое производное
AU2014241390A1 (en) GPR120 agonists for the treatment of type II diabetes
WO2015043342A1 (zh) 新型萘脲类衍生物及其医疗应用
JP2020517619A5 (enExample)
JP2008508365A5 (enExample)
ATE493404T1 (de) Azabicyclo-(3,1,0)-hexan-derivate als modulatoren von dopamin-d3-rezeptoren
JPWO2020061255A5 (enExample)
RU2006102867A (ru) Производные 5-замещенного хиназолинона
RU2008115499A (ru) Новые производные аминокиламидов в качестве антагонистов лигандов рецепторов ccr3
RU2007125661A (ru) Арилоксиэтиламиновые и фенилпиперазиновые производные с сочетанием свойств неполного агонизма к рецепторам дофимина-d2 и ингибирования повторного поглощения серотонина
AU2014385276B2 (en) Isothiazole derivatives as GPR120 agonists for the treatment of Type II diabetes

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20080916